Kymera Therapeutics, Inc.
SEC Filing List
KYMR CIK: 0001815442
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 08/14/2026 | ||||
| SCHEDULE 13G/A | 08/13/2026 | ||||
| 8-K | Current report filing | Kymera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/05/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Kymera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/05/2026 | |
| 3 | Initial statement of beneficial ownershi... | Rooney Terence | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/27/2026 | |
| 8-K | Current report filing | Kymera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/27/2026 | |
| 4 | Statement of changes in beneficial owner... | Rooney Terence | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/27/2026 | |
| 4 | Statement of changes in beneficial owner... | Mainolfi Nello | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/07/2026 | |
| 144 | Filing for proposed sale of securities u... | UBS Financial Services Inc Restricted Sale Group / FA /fa | 07/07/2026 | ||
| 4/A | Amendment to Statement of changes in ben... | Booth Bruce | Kymera Therapeutics, Inc. | 07/02/2026 | |
| No record found. | |||||
| Load More | |||||
